Differential diagnosis and management of focal ground-glass opacities
- PMID: 19047318
- DOI: 10.1183/09031936.00047908
Differential diagnosis and management of focal ground-glass opacities
Abstract
Focal pulmonary ground-glass opacities (GGOs) can be associated with bronchioloalveolar carcinoma. The present retrospective study aimed to test the validity of a multistep approach to discriminate malignant from benign localised (focal) GGOs, identifies useful diagnostic features on computed tomography (CT), and suggests appropriate management guidelines. A stepwise approach, including oral antibiotics, follow-up high-resolution CT (HRCT) 40-60 days later and CT-guided core biopsy, was used. All cases with localised GGOs detected since 2001 were reviewed. CT features were described according to a structured scheme. In total, 40 patients were evaluated. Of these, 11 patients were diagnosed with benign GGOs, 19 patients had lung cancer and 10 were undetermined. Nonpolygonal shape, apparent radial growth and clear-cut margins were associated with a malignant histology. The specificity of CT findings was low. Diagnostic accuracy increased after oral antibiotics, follow-up HRCT and percutaneous core biopsy. Overall, 18 patients underwent surgery for lung cancer. In conclusion, malignant ground-glass opacities have a fairly typical appearance, but some benign lesions closely mimic their malignant counterparts. The stepwise approach adopted in the present study increased the diagnostic specificity and reduced time to definitive diagnosis. Segmentectomy might be the ideal resection volume for such tumours.
Comment in
-
Differential diagnosis and management of focal pulmonary ground-glass opacities.Eur Respir J. 2009 Oct;34(4):1008-9; author reply 1009-10. doi: 10.1183/09031936.00085709. Eur Respir J. 2009. PMID: 19797677 No abstract available.
Similar articles
-
Differential diagnosis and management of focal pulmonary ground-glass opacities.Eur Respir J. 2009 Oct;34(4):1008-9; author reply 1009-10. doi: 10.1183/09031936.00085709. Eur Respir J. 2009. PMID: 19797677 No abstract available.
-
[Localized pure or mixed ground-glass lung opacities].J Radiol. 2009 Nov;90(11 Pt 2):1869-92. doi: 10.1016/s0221-0363(09)73289-5. J Radiol. 2009. PMID: 19953078 Review. French.
-
Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter.J Thorac Cardiovasc Surg. 2007 Oct;134(4):877-82. doi: 10.1016/j.jtcvs.2007.06.010. J Thorac Cardiovasc Surg. 2007. PMID: 17903500
-
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination.Lung Cancer. 2009 Aug;65(2):176-9. doi: 10.1016/j.lungcan.2008.11.013. Epub 2009 Jan 9. Lung Cancer. 2009. PMID: 19135757
-
Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT.Clin Imaging. 2002 Mar-Apr;26(2):95-100. doi: 10.1016/s0899-7071(01)00372-2. Clin Imaging. 2002. PMID: 11852215 Review.
Cited by
-
Synchrotron Radiation Refraction-Contrast Computed Tomography Based on X-ray Dark-Field Imaging Optics of Pulmonary Malignancy: Comparison with Pathologic Examination.Cancers (Basel). 2024 Feb 16;16(4):806. doi: 10.3390/cancers16040806. Cancers (Basel). 2024. PMID: 38398196 Free PMC article.
-
A narrative review of the clinical approach to subsolid pulmonary nodules.Ann Transl Med. 2023 Mar 15;11(5):217. doi: 10.21037/atm-22-5246. Epub 2023 Mar 10. Ann Transl Med. 2023. PMID: 37007560 Free PMC article. Review.
-
DTLCx: An Improved ResNet Architecture to Classify Normal and Conventional Pneumonia Cases from COVID-19 Instances with Grad-CAM-Based Superimposed Visualization Utilizing Chest X-ray Images.Diagnostics (Basel). 2023 Feb 2;13(3):551. doi: 10.3390/diagnostics13030551. Diagnostics (Basel). 2023. PMID: 36766662 Free PMC article.
-
Differential diagnosis of benign and malignant patchy ground-glass opacity by thin-section computed tomography.BMC Cancer. 2022 Nov 23;22(1):1206. doi: 10.1186/s12885-022-10338-4. BMC Cancer. 2022. PMID: 36424538 Free PMC article.
-
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation.Biomedicines. 2022 Oct 9;10(10):2525. doi: 10.3390/biomedicines10102525. Biomedicines. 2022. PMID: 36289785 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical